Drug intelligence / Profile preview

general anesthesia + opioid analgesia

Development stage
Unknown
Modality
Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Peptides
Administration
Intravenous, Inhalation
01

Overview

General anesthesia + opioid analgesia refers to the combined use of general anesthetic agents and opioid analgesics during surgical procedures. General anesthetics induce a reversible state of unconsciousness, amnesia, and immobility, typically through intravenous or inhalational agents such as propofol, sevoflurane, desflurane, or isoflurane. Opioid analgesics (such as fentanyl, morphine, hydromorphone) are administered concurrently to provide potent pain relief by binding to opioid receptors in the central nervous system. This combination is foundational in balanced or multimodal anesthesia practice—using multiple drugs at lower doses to maximize efficacy while minimizing side effects. The mechanism of action involves general anesthetics depressing central nervous system activity (primarily via GABAergic pathways), while opioids activate mu-, delta-, and kappa-opioid receptors to inhibit nociceptive transmission and alter pain perception[2][3][4].

Other names
balanced general anesthesiamultimodal general anesthesia
02

Targets

KOR (Kappa opioid receptor)GABRR (GABA-A receptor subunit rho)MOR (Mu opioid receptor)DOR (Opioid Receptor Delta 1)

Beyond the preview

Go deeper on general anesthesia + opioid analgesia.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on general anesthesia + opioid analgesia.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call